These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 28099433)

  • 1. Defining Seropositivity Thresholds for Use in Trachoma Elimination Studies.
    Migchelsen SJ; Martin DL; Southisombath K; Turyaguma P; Heggen A; Rubangakene PP; Joof H; Makalo P; Cooley G; Gwyn S; Solomon AW; Holland MJ; Courtright P; Willis R; Alexander ND; Mabey DC; Roberts CH
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005230. PubMed ID: 28099433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological and PCR-based markers of ocular Chlamydia trachomatis transmission in northern Ghana after elimination of trachoma as a public health problem.
    Senyonjo LG; Debrah O; Martin DL; Asante-Poku A; Migchelsen SJ; Gwyn S; deSouza DK; Solomon AW; Agyemang D; Biritwum-Kwadwo N; Marfo B; Bakajika D; Mensah EO; Aboe A; Koroma J; Addy J; Bailey R
    PLoS Negl Trop Dis; 2018 Dec; 12(12):e0007027. PubMed ID: 30550537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serology reflects a decline in the prevalence of trachoma in two regions of The Gambia.
    Migchelsen SJ; Sepúlveda N; Martin DL; Cooley G; Gwyn S; Pickering H; Joof H; Makalo P; Bailey R; Burr SE; Mabey DCW; Solomon AW; Roberts CH
    Sci Rep; 2017 Nov; 7(1):15040. PubMed ID: 29118442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pgp3 seroprevalence and associations with active trachoma and ocular Chlamydia trachomatis infection in Malawi: cross-sectional surveys in six evaluation units.
    Burr SE; Hart J; Samikwa L; Chaima D; Cooley G; Martin D; Masika M; Solomon AW; Bailey RL; Kalua K
    PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007749. PubMed ID: 31658258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community-level chlamydial serology for assessing trachoma elimination in trachoma-endemic Niger.
    Kim JS; Oldenburg CE; Cooley G; Amza A; Kadri B; Nassirou B; Cotter SY; Stoller NE; West SK; Bailey RL; Keenan JD; Gaynor BD; Porco TC; Lietman TM; Martin DL
    PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007127. PubMed ID: 30689671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of signs of trachoma, ocular Chlamydia trachomatis infection and antibodies to Pgp3 in residents of Kiritimati Island, Kiribati.
    Cama A; Müller A; Taoaba R; Butcher RMR; Itibita I; Migchelsen SJ; Kiauea T; Pickering H; Willis R; Roberts CH; Bakhtiari A; Le Mesurier RT; Alexander NDE; Martin DL; Tekeraoi R; Solomon AW;
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005863. PubMed ID: 28898240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serology for trachoma surveillance after cessation of mass drug administration.
    Martin DL; Bid R; Sandi F; Goodhew EB; Massae PA; Lasway A; Philippin H; Makupa W; Molina S; Holland MJ; Mabey DC; Drakeley C; Lammie PJ; Solomon AW
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003555. PubMed ID: 25714363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can We Use Antibodies to Chlamydia trachomatis as a Surveillance Tool for National Trachoma Control Programs? Results from a District Survey.
    West SK; Munoz B; Weaver J; Mrango Z; Dize L; Gaydos C; Quinn TC; Martin DL
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004352. PubMed ID: 26771906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the reproducibility of a serological test for antibodies to Chlamydia trachomatis pgp3: A potential surveillance tool for trachoma programs.
    Kaur H; Dize L; Munoz B; Gaydos C; West SK
    J Microbiol Methods; 2018 Apr; 147():56-58. PubMed ID: 29501689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Performance of Immunoassays to Measure Antibodies to the Chlamydia trachomatis Antigen Pgp3 in Different Epidemiological Settings for Trachoma.
    Gwyn S; Nute AW; Sata E; Tadesse Z; Chernet A; Haile M; Zeru T; Bethea D; Laurent C; Callahan EK; Nash SD; Martin DL
    Am J Trop Med Hyg; 2021 Aug; 105(5):1362-1367. PubMed ID: 34398819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trachoma, Anti-Pgp3 Serology, and Ocular Chlamydia trachomatis Infection in Papua New Guinea.
    Macleod CK; Butcher R; Javati S; Gwyn S; Jonduo M; Abdad MY; Roberts CH; Keys D; Koim SP; Ko R; Garap J; Pahau D; Houinei W; Martin DL; Pomat WS; Solomon AW
    Clin Infect Dis; 2021 Feb; 72(3):423-430. PubMed ID: 31965155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The utility of serology for elimination surveillance of trachoma.
    Pinsent A; Solomon AW; Bailey RL; Bid R; Cama A; Dean D; Goodhew B; Gwyn SE; Jack KR; Kandel RP; Kama M; Massae P; Macleod C; Mabey DCW; Migchelsen S; Müller A; Sandi F; Sokana O; Taoaba R; Tekeraoi R; Martin DL; White MT
    Nat Commun; 2018 Dec; 9(1):5444. PubMed ID: 30575720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of platforms for testing antibodies to Chlamydia trachomatis antigens in the Democratic Republic of the Congo and Togo.
    Gwyn S; Awoussi MS; Bakhtiari A; Bronzan RN; Crowley K; Harding-Esch EM; Kassankogno Y; Kilangalanga JN; Makangila F; Mupoyi S; Ngondi J; Ngoyi B; Palmer S; Randall JM; Seim A; Solomon AW; Stewart R; Togbey K; Uvon PA; Martin DL
    Sci Rep; 2021 Mar; 11(1):7225. PubMed ID: 33790370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Which members of a community need antibiotics to control trachoma? Conjunctival Chlamydia trachomatis infection load in Gambian villages.
    Burton MJ; Holland MJ; Faal N; Aryee EA; Alexander ND; Bah M; Faal H; West SK; Foster A; Johnson GJ; Mabey DC; Bailey RL
    Invest Ophthalmol Vis Sci; 2003 Oct; 44(10):4215-22. PubMed ID: 14507864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profound and sustained reduction in Chlamydia trachomatis in The Gambia: a five-year longitudinal study of trachoma endemic communities.
    Burton MJ; Holland MJ; Makalo P; Aryee EA; Sillah A; Cohuet S; Natividad A; Alexander ND; Mabey DC; Bailey RL
    PLoS Negl Trop Dis; 2010 Oct; 4(10):. PubMed ID: 20957147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of
    Gwyn SE; Xiang L; Kandel RP; Dean D; Gambhir M; Martin DL
    Am J Trop Med Hyg; 2018 Jan; 98(1):216-220. PubMed ID: 29141720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of Trachoma from Achham District, Nepal: A Cross-Sectional Study from the Nepal National Trachoma Program.
    Pant BP; Bhatta RC; Chaudhary JS; Awasthi S; Mishra S; Sharma S; Cuddapah PA; Gwyn SE; Stoller NE; Martin DL; Keenan JD; Lietman TM; Gaynor BD
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004462. PubMed ID: 26871898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community seroprevalence survey for yaws and trachoma in the Western Division of Fiji.
    Cocks N; Rainima-Qaniuci M; Yalen C; Macleod C; Nakolinivalu A; Migchelsen S; Roberts CH; Butcher R; Kama M; Mabey D; Marks M
    Trans R Soc Trop Med Hyg; 2016 Dec; 110(10):582-587. PubMed ID: 27852877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance for peri-elimination trachoma recrudescence: Exploratory studies in Ghana.
    Senyonjo L; Addy J; Martin DL; Agyemang D; Yeboah-Manu D; Gwyn S; Marfo B; Asante-Poku A; Aboe A; Mensah E; Solomon AW; Bailey RL
    PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009744. PubMed ID: 34543293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population-Based Prevalence of
    Nash SD; Astale T; Nute AW; Bethea D; Chernet A; Sata E; Zerihun M; Gessese D; Ayenew G; Ayele Z; Melak B; Haile M; Zeru T; Tadesse Z; Arnold BF; Callahan EK; Martin DL
    Am J Trop Med Hyg; 2021 Jan; 104(1):207-215. PubMed ID: 33200728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.